BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19896448)

  • 1. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage.
    Cai Y; Rodriguez S; Rameswaran R; Draghia-Akli R; Juba RJ; Hebel H
    Vaccine; 2010 Feb; 28(8):2046-52. PubMed ID: 19896448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies.
    Przybylowski M; Bartido S; Borquez-Ojeda O; Sadelain M; Rivière I
    Vaccine; 2007 Jun; 25(27):5013-24. PubMed ID: 17537555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine manufacture: scale and quality.
    Cai Y; Rodriguez S; Hebel H
    Expert Rev Vaccines; 2009 Sep; 8(9):1277-91. PubMed ID: 19722898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.
    Quaak SG; van den Berg JH; Toebes M; Schumacher TN; Haanen JB; Beijnen JH; Nuijen B
    Eur J Pharm Biopharm; 2008 Oct; 70(2):429-38. PubMed ID: 18606527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT.
    Quaak SG; Nuijen B; Haanen JB; Beijnen JH
    J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pilot-scale production and quality control of multiepitope hepatitis B virus DNA vaccine].
    Guo Y; Hui CY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):118-20. PubMed ID: 19218129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA purification.
    Stadler J; Lemmens R; Nyhammar T
    J Gene Med; 2004 Feb; 6 Suppl 1():S54-66. PubMed ID: 14978751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression.
    Carnes AE; Luke JM; Vincent JM; Schukar A; Anderson S; Hodgson CP; Williams JA
    Biotechnol Bioeng; 2011 Feb; 108(2):354-63. PubMed ID: 20830679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved downstream process for the production of plasmid DNA for gene therapy.
    Urthaler J; Buchinger W; Necina R
    Acta Biochim Pol; 2005; 52(3):703-11. PubMed ID: 16175245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms.
    Bo H; Wang J; Chen Q; Shen H; Wu F; Shao H; Huang S
    Pharm Biol; 2013 Jan; 51(1):42-8. PubMed ID: 23013372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of supercoiled plasmid.
    Green AP
    Methods Mol Med; 2000; 29():1-9. PubMed ID: 21374304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy.
    Otero M; Calarota SA; Dai A; De Groot AS; Boyer JD; Weiner DB
    Vaccine; 2006 May; 24(21):4461-70. PubMed ID: 16137803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid DNA production combining antibiotic-free selection, inducible high yield fermentation, and novel autolytic purification.
    Carnes AE; Hodgson CP; Luke JM; Vincent JM; Williams JA
    Biotechnol Bioeng; 2009 Oct; 104(3):505-15. PubMed ID: 19557837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of process flow sheets for the purification of supercoiled plasmids for gene therapy applications.
    Ferreira GN; Cabral JM; Prazeres DM
    Biotechnol Prog; 1999; 15(4):725-31. PubMed ID: 10441364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid fermentation process for DNA immunization applications.
    Carnes AE; Williams JA
    Methods Mol Biol; 2014; 1143():197-217. PubMed ID: 24715290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of IS1 transposition in plasmid amplification mutants of E. coli clones producing DNA vaccines.
    Prather KL; Edmonds MC; Herod JW
    Appl Microbiol Biotechnol; 2006 Dec; 73(4):815-26. PubMed ID: 16941177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of isopropanol and ammonium sulfate precipitation steps in the purification of plasmid DNA.
    Freitas SS; Santos JA; Prazeres DM
    Biotechnol Prog; 2006; 22(4):1179-86. PubMed ID: 16889396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine.
    Okonkowski J; Kizer-Bentley L; Listner K; Robinson D; Chartrain M
    Biotechnol Prog; 2005; 21(4):1038-47. PubMed ID: 16080681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale purification of pharmaceutical-grade plasmid DNA using tangential flow filtration and multi-step chromatography.
    Sun B; Yu X; Yin Y; Liu X; Wu Y; Chen Y; Zhang X; Jiang C; Kong W
    J Biosci Bioeng; 2013 Sep; 116(3):281-6. PubMed ID: 23660074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.